Abstract
Streptococcal infections can cause rheumatic heart disease. Polysaccharide from group A streptococci may induce the production of antibodies by an animal which then react against its own valvular glycoproteins
Similar content being viewed by others
References
Kaplan, M., J. Exp. Med., 110 643 (1964).
Suchy, M. L., and Kaplan, M., J. Immunol., 90, 595 (1963).
Robert, L., Parlebas, J., Oudea, P., Zweibaum, A., and Robert, B., in Structure and Function of Connective and Skeletal Tissue NATO-Symposium, 406 (Butterworth, London, 1965).
Robert, L., Oudea, P., Zweibaum, A., Parlebas, J., and Robert, B., in Protides of Biological Fluids (edit. by Peeters), 12, 110 (Elsevier, Amsterdam, 1964).
Fuller, A. T., Brit. J. Exp. Path., 19, 129 (1938).
McCarty, M., J. Exp. Med., 108, 311 (1958).
Hämmerling, M., dissert., Albert Luwigs Universität, Freiburg im Breisgau (1965).
Kabat, E. A., and Mayer, M. M., Experimental Immunochemistry (Thomas. Springfield, Illinois, 1961).
Markham, R., Biochem. J., 36, 790 (1942).
Halpern, B. N., Jacob, M., Binaghi, R., and Parlebas, J., Rev. Franc. d'Allergie, 1, 201 (1961).
Lewy, H. B., and Sober, H. A., Proc. Soc. Exp. Biol. and Med., 103, 250 (1960).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GOLDSTEIN, I., HALPERN, B. & ROBERT, L. Immunological Relationship between Streptococcus A Polysaccharide and the Structural Glycoproteins of Heart Valve. Nature 213, 44–47 (1967). https://doi.org/10.1038/213044a0
Issue Date:
DOI: https://doi.org/10.1038/213044a0
- Springer Nature Limited
This article is cited by
-
Acute rheumatic fever and rheumatic heart disease
Nature Reviews Disease Primers (2016)
-
Rheumatic fever revisited
Nature Reviews Cardiology (2014)
-
Molecular mimicry between streptococcal pyrogenic exotoxin B and endothelial cells
Laboratory Investigation (2010)
-
Changes of manifestations of 122 patients with rheumatic fever in South China during last decade
Rheumatology International (2009)
-
Rheumatic Heart Disease
Clinical Immunotherapeutics (1995)